NCT07009457 2025-07-04Phase I Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung CancerSuzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 1 Recruiting48 enrolled